Cell Signaling Technology

Phospho-SGK1 (Ser78) (D36D11) Rabbit Monoclonal Antibody

#5599 · $178

100
Citing papers
9.3k
Combined citations
Supplier page Find this product

Research areas

PARP inhibition in cancer therapy17DNA Repair Mechanisms16CRISPR and Genetic Engineering8Pancreatic function and diabetes7Immune Cell Function and Interaction6Cell Adhesion Molecules Research6T-cell and B-cell Immunology6Ubiquitin and proteasome pathways6

Papers citing this product

1
Fibroblast Growth Factor-21 Improves Pancreatic β-Cell Function and Survival by Activation of Extracellular Signal–Regulated Kinase 1/2 and Akt Signaling Pathways
Diabetes·2006·491 cit.·DOI
2
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions
Nature·2018·415 cit.·DOI
3
LEF-1 and TCF-1 orchestrate TFH differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6
Nature Immunology·2015·326 cit.·DOI
4
Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency
Molecular Cell·2021·315 cit.·DOI
5
Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy
Nature Communications·2020·292 cit.·DOI
6
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
Nature Communications·2017·278 cit.·DOI
7
Differential αv integrin–mediated Ras-ERK signaling during two pathways of angiogenesis
The Journal of Cell Biology·2003·257 cit.·DOI
8
DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression
Nature Communications·2015·229 cit.·DOI
9
Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity
Journal of Clinical Investigation·2014·216 cit.·DOI
10
Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis
Nature Communications·2018·179 cit.·DOI